Ultrasound heart and liver check for heart risk in fatty liver disease
Part of Digestive system, Heart & circulation, Hormones & metabolism clinical trials.
This study uses ultrasound to measure fat in your liver and check your heart's function to better understand your risk for heart problems. It may help doctors find ways to prevent heart disease in people with fatty liver disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with fatty liver disease (MASLD) by imaging or biopsy.
- You have at least one heart or metabolic risk factor, such as being overweight (BMI 25 or higher), having type 2 diabetes, or having abnormal cholesterol levels.
- You do not drink a lot of alcohol (more than 20 grams per day for women, 30 grams for men).
- You do not have other causes of liver fat, like viral hepatitis or autoimmune liver disease.
- You do not have advanced heart failure or have had a heart attack or stroke in the last 6 months, and you are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new ultrasound device that uses sound waves to measure fat in the liver without needles or surgery. It is for people with a type of fatty liver disease called MASLD or MASH, who are already getting an MRI to check their liver.
This study explores if a new ultrasound technique can detect fatty liver disease in children. It aims to find a simpler, safer way to check liver health without needing an MRI or biopsy.
This study uses a special ultrasound technique, called shear wave elastography, to measure liver stiffness during an endoscopic ultrasound (EUS) procedure. It aims to see how well this new method detects liver scarring (fibrosis) in people with fatty liver disease, compared to standard tests like FibroScan and liver biopsy.
This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.
This study tests a new device called LiverScope® that scans your liver to detect fatty liver disease (MASLD). The scan uses special imaging technology and may help doctors diagnose liver disease more quickly and accurately.
This study looks at whether a simple blood test (FIB-4) can help detect liver scarring in people with obesity. It may help doctors identify liver problems earlier.
Hear when a new MASLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.